[Use of Hyperstat for arresting hypertensive crises]. 1978

A P Golikov, and V K Babkov, and A P Borisenko, and V I Ivleva

The indices of central hemodynamics were determined in 112 patients with hypertensive disease during a crisis and in its arrest with hyperstat by means of integral rheography. The condition of the sympatheticoadrenal and kallikrein-kinin systems was studied. It was found that hyperstat normalizes arterial pressure in 5--6 minutes by reducing the initially increased general peripheral resistance and increasing the blood stroke and minute volumes as well as by reducing the content of adrenaline. The indices of the blood kallikrein-kinin system showed a tendency to return to normal values 24 hours after hyperstat administration. The drug caused no complications, only in two patients deterioration of myocardial blood supply was noted. The authors claim that hyperstat is a highly effective agent for arresting hypertensive crises.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007610 Kallikreins Proteolytic enzymes from the serine endopeptidase family found in normal blood and urine. Specifically, Kallikreins are potent vasodilators and hypotensives and increase vascular permeability and affect smooth muscle. They act as infertility agents in men. Three forms are recognized, PLASMA KALLIKREIN (EC 3.4.21.34), TISSUE KALLIKREIN (EC 3.4.21.35), and PROSTATE-SPECIFIC ANTIGEN (EC 3.4.21.77). Kallikrein,Kininogenase,Callicrein,Dilminal,Kallidinogenase,Kalliginogenase,Kallikrein A,Kallikrein B',Kallikrein Light Chain,Kinin-Forming Enzyme,Padutin,alpha-Kallikrein,beta-Kallikrein,beta-Kallikrein B,Enzyme, Kinin-Forming,Kinin Forming Enzyme,Light Chain, Kallikrein,alpha Kallikrein,beta Kallikrein,beta Kallikrein B
D007705 Kinins A generic term used to describe a group of polypeptides with related chemical structures and pharmacological properties that are widely distributed in nature. These peptides are AUTACOIDS that act locally to produce pain, vasodilatation, increased vascular permeability, and the synthesis of prostaglandins. Thus, they comprise a subset of the large number of mediators that contribute to the inflammatory response. (From Goodman and Gilman's The Pharmacologic Basis of Therapeutics, 8th ed, p588) Kinin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003981 Diazoxide A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group. Hyperstat,Proglycem
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004630 Emergencies Situations or conditions requiring immediate intervention to avoid serious adverse results. Emergency
D005260 Female Females

Related Publications

A P Golikov, and V K Babkov, and A P Borisenko, and V I Ivleva
November 1978, Kardiologiia,
A P Golikov, and V K Babkov, and A P Borisenko, and V I Ivleva
January 1978, Terapevticheskii arkhiv,
A P Golikov, and V K Babkov, and A P Borisenko, and V I Ivleva
August 1979, Kardiologiia,
A P Golikov, and V K Babkov, and A P Borisenko, and V I Ivleva
August 1980, Vrachebnoe delo,
A P Golikov, and V K Babkov, and A P Borisenko, and V I Ivleva
January 1981, Medicinski pregled,
A P Golikov, and V K Babkov, and A P Borisenko, and V I Ivleva
February 1983, Polski tygodnik lekarski (Warsaw, Poland : 1960),
A P Golikov, and V K Babkov, and A P Borisenko, and V I Ivleva
July 1991, Vrachebnoe delo,
A P Golikov, and V K Babkov, and A P Borisenko, and V I Ivleva
August 1991, Kardiologiia,
A P Golikov, and V K Babkov, and A P Borisenko, and V I Ivleva
December 1999, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
A P Golikov, and V K Babkov, and A P Borisenko, and V I Ivleva
March 1983, Primary care,
Copied contents to your clipboard!